is tirzepatide on shortage Compounding pharmacies can resume making as FDA reconsiders Addressing the Weight Loss Injectable

Plus, blood sugar control can involve many other possible factors including blood chemistry, environment, health status, and genetics that may vary from one person to another

If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly

It is particularly beneficial for those who have a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with obesity-related health conditions such as type 2 diabetes or hypertension

Patients carrying certain allele combinations may require lower starting doses or experience faster titration, while others benefit from higher maintenance doses

Tirzepatide was previously approved as Mounjaro to treat type 2 diabetes in the U.S